
Faster, better, together: Biopharma collaboration trends in the pandemic, and the future of medicine
Speakers

Justin Moran, PhD
Executive Director, Head of Early Bioprocess Development
Pfizer Vaccines
The Impact of a Pandemic on Process Development

Jennifer Grossman, PhD
Business Development Manager, Pilot Bioproduction Facility
Walter Reed Army Institute of Research
Lessons on flexibility and scaling-up fast: how the biopharmaceutical industry is preparing to face the next pandemic

Claudia Berrón, MBA
Senior Vice President, Proprietary Research Products & Materials
Avantor
The impact of decentralization and digitization on clinical trial logistics, kits, and sample management

Nandu Deorkar, PhD
Ph.D., MBA, Senior Vice President, Research & Development – Biopharma Production
Avantor
Nandu Deorkar is Senior Vice President, Biopharma Production Research & Development for Avantor. He is responsible for innovation strategy and planning, and execution of new products and technology development. During his more than 25-year career in research & development, Dr. Deorkar has been leading teams working on various aspects of upstream and downstream bioprocessing, single use systems, chemical/polymer R&D, drug development, formulation, drug delivery technologies, process development, and technology transfer. He has published more than 30 articles and holds more than 20 patents. Dr. Deorkar received Ph.D. from Indian Institute of Technology, Mumbai, India and MBA in Marketing from Fairleigh Dickinson University, Madison, NJ, USA.

Pranav Vengsarkar, PhD
Manager, Process Development, Research Biopharma Production
Avantor
Enhanced raw material delivery strategies: Debottlenecking of buffer and media preparation in mAbs and novel therapeutics